0001209191-19-061048.txt : 20191217 0001209191-19-061048.hdr.sgml : 20191217 20191217200024 ACCESSION NUMBER: 0001209191-19-061048 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191213 FILED AS OF DATE: 20191217 DATE AS OF CHANGE: 20191217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mahatme Sandesh CENTRAL INDEX KEY: 0001511034 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 191291083 MAIL ADDRESS: STREET 1: C/O CELGENE CORPORATION STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-13 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001511034 Mahatme Sandesh 215 FIRST STREET, SUITE 415 CAMBRIDGE MA 02142 0 1 0 0 EVP, CFO & CBO Common Stock 2019-12-13 4 M 0 4319 13.71 A 34498 D Common Stock 2019-12-13 4 M 0 4138 13.71 A 38636 D Common Stock 2019-12-13 4 M 0 10466 23.85 A 49102 D Common Stock 2019-12-13 4 M 0 69479 29.03 A 118581 D Common Stock 2019-12-13 4 M 0 21875 32.63 A 140456 D Common Stock 2019-12-13 4 M 0 14723 34.92 A 155179 D Common Stock 2019-12-13 4 S 0 125000 125.50 D 30179 D Common Stock 12012 I By trust Stock option (right to buy) 13.71 2019-12-13 4 M 0 4319 0.00 D 2017-02-28 2026-02-28 Common Stock 4319 3085 D Stock option (right to buy) 13.71 2019-12-13 4 M 0 4138 0.00 D 2016-09-09 2026-02-28 Common Stock 4138 2633 D Stock option (right to buy) 23.85 2019-12-13 4 M 0 10466 0.00 D 2013-11-05 2022-11-05 Common Stock 10466 0 D Stock option (right to buy) 29.03 2019-12-13 4 M 0 69479 0.00 D 2015-02-28 2024-02-28 Common Stock 69479 0 D Stock option (right to buy) 32.63 2019-12-13 4 M 0 21875 0.00 D 2018-03-10 2027-03-10 Common Stock 21875 10874 D Stock option (right to buy) 34.92 2019-12-13 4 M 0 14723 0.00 D 2014-06-04 2023-06-04 Common Stock 14723 39277 D This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. /s/ David Tyronne Howton, as Attorney-in-Fact for Sandesh Mahatme 2019-12-17